Compare · CSII vs MMM
CSII vs MMM
Side-by-side comparison of Cardiovascular Systems Inc. (CSII) and 3M Company (MMM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CSII and MMM operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MMM is the larger of the two at $84.41B, about 120.8x CSII ($698.7M).
- MMM has hit the wire 8 times in the past 4 weeks while CSII has been quiet.
- MMM has more recent analyst coverage (25 ratings vs 8 for CSII).
- Company
- Cardiovascular Systems Inc.
- 3M Company
- Price
- $19.99+0.05%
- $161.93-0.78%
- Market cap
- $698.7M
- $84.41B
- 1M return
- -
- +6.77%
- 1Y return
- -
- +8.04%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 1981
- News (4w)
- 0
- 8
- Recent ratings
- 8
- 25
Cardiovascular Systems Inc.
Cardiovascular Systems, Inc., a medical device company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. The company has a partnership with Chansu Vascular Technologies, LLC to develop peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.
3M Company
3M Company develops, manufactures, and markets various products worldwide. It operates through four business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Safety and Industrial segment offers personal safety products, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules to industrial, electrical, and safety markets. The Transportation and Electronics provides electronics, such as display materials and systems, electronic materials solutions; automotive and aerospace, and commercial solutions; advanced materials; and transportation safety products to transportation and electronic original equipment manufacturer customers. The Health Care segment offers medical and surgical supplies, skin health and infection prevention products, oral care, separation and purification sciences, health information systems, drug delivery systems, and food safety products to healthcare industry. The Consumer segment provides home improvement, home care, and consumer health care products, as well as stationery and office supplies to various consumers. This segment is also involved in the retail auto care business. It offers its products through various e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers, as well as directly to users. 3M Company has a strategic collaboration with Merry Maids in residential cleaning sector; and collaborations with The Infectious Disease Research Institute and Duke Human Vaccine Institute to create a vaccine candidate with potential to provide protection against multiple variants of SARS-CoV-2. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Latest CSII
- SEC Form SC 13G/A filed by Cardiovascular Systems Inc. (Amendment)
- SEC Form 15-12G filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
Latest MMM
- 3M and Airbus announce agreement to advance A220 passenger comfort and aircraft performance through advanced insulation technology
- 3M launches Ask 3M, an AI-powered tool for faster access to technical expertise
- Goldman resumed coverage on 3M with a new price target
- Bernstein initiated coverage on 3M with a new price target
- Director Rumsey Jennifer was granted 1,196 shares (SEC Form 4)
- SEC Form 3 filed by new insider Rumsey Jennifer
- 3M Company filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- 3M Announces New Board Appointment
- SEC Form SD filed by 3M Company
- 3M Announces Upcoming Investor Event